Agilon Health (NYSE:AGL) Trading 5.4% Higher – What’s Next?

Agilon Health, Inc. (NYSE:AGL)’s share price was up 5.4% on Thursday . The stock traded as high as $100.00 and last traded at $98.6820. 33,811 shares changed hands during mid-day trading, a decline of 90% from the average session volume of 354,760 shares. The stock had previously closed at $93.64.

Analyst Ratings Changes

Several analysts have recently commented on AGL shares. Robert W. Baird set a $116.00 price target on shares of Agilon Health in a research report on Thursday, August 6th. Truist Financial set a $112.00 price objective on Agilon Health and gave the stock a “hold” rating in a research report on Thursday, August 6th. Jefferies Financial Group raised Agilon Health from a “hold” rating to a “buy” rating and raised their target price for the stock from $27.50 to $48.00 in a research note on Thursday, May 7th. Deutsche Bank Aktiengesellschaft upgraded Agilon Health from a “hold” rating to a “buy” rating and lifted their target price for the company from $33.00 to $49.00 in a research report on Thursday, May 7th. Finally, TD Cowen reaffirmed a “hold” rating and issued a $55.00 price target (up from $17.00) on shares of Agilon Health in a research note on Monday, May 11th. Five research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and two have given a Sell rating to the company. Based on data from MarketBeat.com, Agilon Health currently has an average rating of “Hold” and a consensus target price of $91.30.

Agilon Health Price Performance

The company has a market capitalization of $1.62 billion, a PE ratio of -6.75 and a beta of 3.01. The company has a debt-to-equity ratio of 0.07, a current ratio of 1.08 and a quick ratio of 1.08. The stock’s 50 day simple moving average is $105.84 and its 200-day simple moving average is $60.88.

Agilon Health (NYSE:AGL) last posted its quarterly earnings data on Wednesday, August 5th. The company reported $1.04 EPS for the quarter, beating the consensus estimate of $0.14 by $0.90. The business had revenue of $1.49 billion during the quarter, compared to analyst estimates of $1.45 billion. Agilon Health had a negative net margin of 3.92% and a negative return on equity of 119.38%. As a group, equities analysts forecast that Agilon Health, Inc. will post -2.95 earnings per share for the current fiscal year.

Hedge Funds Weigh In On Agilon Health

Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. LPL Financial LLC increased its position in shares of Agilon Health by 213.4% during the fourth quarter. LPL Financial LLC now owns 44,055 shares of the company’s stock worth $30,000 after acquiring an additional 30,000 shares during the period. Krilogy Financial LLC purchased a new position in Agilon Health in the fourth quarter valued at $34,000. CIBC Bancorp USA Inc. purchased a new position in Agilon Health in the third quarter valued at $34,000. Merit Financial Group LLC acquired a new position in Agilon Health during the 4th quarter worth $35,000. Finally, Focus Partners Advisor Solutions LLC acquired a new position in Agilon Health during the 4th quarter worth $53,000.

About Agilon Health

Agilon Health (NYSE: AGL) is a healthcare company that partners with independent primary care physicians to deliver value-based care for Medicare beneficiaries. Through risk-sharing arrangements, Agilon assumes financial responsibility for patient populations, enabling physicians to focus on preventive and proactive health management. The company provides the administrative, clinical and operational infrastructure needed to support comprehensive care delivery.

Agilon’s platform encompasses data analytics, care management, patient engagement tools and population health programs.